A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors.
about
A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A phase I, dose escalation, ph ...... ts with advanced solid tumors.
@en
A phase I, dose escalation, ph ...... ts with advanced solid tumors.
@nl
type
label
A phase I, dose escalation, ph ...... ts with advanced solid tumors.
@en
A phase I, dose escalation, ph ...... ts with advanced solid tumors.
@nl
prefLabel
A phase I, dose escalation, ph ...... ts with advanced solid tumors.
@en
A phase I, dose escalation, ph ...... ts with advanced solid tumors.
@nl
P2093
P2860
P1476
A phase I, dose escalation, ph ...... ts with advanced solid tumors.
@en
P2093
B Milojkovic Kerklaan
J H M Schellens
L Reyderman
M Megui-Roelvink
M P J Lolkema
P O Witteveen
P2860
P2888
P304
P356
10.1007/S10637-016-0344-9
P577
2016-04-02T00:00:00Z